Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT03664752. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT03664752
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch Health Americas, Inc.
- Industry
- Enrollment
- 585 participants
Conditions and interventions
Conditions
Interventions
- IDP-120 Gel Drug
- IDP-120 Vehicle Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2018
- Primary completion
- May 6, 2020
- Completion
- May 6, 2020
- Last update posted
- Mar 28, 2023
2018 – 2020
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 210 | Rogers | Arkansas | 72758 | — |
| Valeant Site 201 | Manhattan Beach | California | 90266 | — |
| Valeant Site 206 | San Diego | California | 92123 | — |
| Valeant Site 218 | San Diego | California | 92123 | — |
| Valeant Site 204 | Boynton Beach | Florida | 33437 | — |
| Valeant Site 217 | Brandon | Florida | 33511 | — |
| Valeant Site 202S | Miami | Florida | 33144 | — |
| Valeant Site 214 | Tampa | Florida | 33606 | — |
| Valeant Site 222 | Snellville | Georgia | 30078 | — |
| Valeant Site 215 | Boise | Idaho | 83704 | — |
| Valeant Site 205 | Metairie | Louisiana | 70006 | — |
| Valeant Site 216 | Clarkston | Michigan | 48346 | — |
| Valeant Site 221 | Clinton Township | Michigan | 48038 | — |
| Valeant Site 227 | Rochester | New York | 14623 | — |
| Valeant Site 229 | Raleigh | North Carolina | 27612 | — |
| Valeant Site 230 | Raleigh | North Carolina | 27612 | — |
| Valeant Site 213 | San Antonio | Texas | 78213 | — |
| Valeant Site 223 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03664752, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03664752 live on ClinicalTrials.gov.